Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PROCEPT BioRobotics (PRCT) Operating Income (2020 - 2025)

PROCEPT BioRobotics (PRCT) has disclosed Operating Income for 6 consecutive years, with -$31.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Operating Income fell 57.48% to -$31.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$103.9 million, a 7.5% decrease, with the full-year FY2025 number at -$103.9 million, down 7.5% from a year prior.
  • Operating Income was -$31.0 million for Q4 2025 at PROCEPT BioRobotics, down from -$23.2 million in the prior quarter.
  • In the past five years, Operating Income ranged from a high of -$11.3 million in Q1 2021 to a low of -$31.0 million in Q4 2025.
  • A 5-year average of -$22.2 million and a median of -$22.8 million in 2024 define the central range for Operating Income.
  • Peak YoY movement for Operating Income: tumbled 80.7% in 2023, then surged 33.32% in 2024.
  • PROCEPT BioRobotics' Operating Income stood at -$16.8 million in 2021, then plummeted by 48.77% to -$25.0 million in 2022, then decreased by 18.04% to -$29.6 million in 2023, then soared by 33.32% to -$19.7 million in 2024, then crashed by 57.48% to -$31.0 million in 2025.
  • Per Business Quant, the three most recent readings for PRCT's Operating Income are -$31.0 million (Q4 2025), -$23.2 million (Q3 2025), and -$22.2 million (Q2 2025).